Last update :
27/11/2024
Antibiotic   Cefepime dihydrochloride  
Eye-drops
injection
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References pdf
   Chemical structure  

Eye-drops
Stability of pharmaceutical preparations   Eye-drops   Stability of pharmaceutical preparations : Cefepime dihydrochloride     
Container Origine excipient Temperature Storage Duration of stability References
Not specified Commercial Drug product 1,725 g
Maxipime®
Water for injection 98,3 g
4°C Protect from light
24 Day
3182

Not specified Commercial Drug product 1,725 g
Maxipime®
Citrate buffer pH 6.25 - 302 mOsmol/L 98,3 g
4°C Protect from light
27 Day
3182

Not specified Commercial Drug product 1,725 g
Maxipime®
Borate Phenylmercuric 0,04% 2,5 g
ßphenylethylalcool 0,4 g
Citrate buffer pH 6.25 - 302 mOsmol/L 95,4 g
4°C Protect from light
27 Day
3182

Not specified Commercial Drug product 1,725 g
Maxipime®
polyvinyl alcohol ŋ = 42.3 mPas pH 4.48 49,13 g
Citrate buffer pH 6.05 - 586 mOsmol/L 49,13 g
4°C Protect from light
21 Day
3182

Not specified Commercial Drug product 1,725 g
Maxipime®
polyvinyl alcohol ŋ = 42.3 mPas pH 4.48 47,70 g
Borate Phenylmercuric 0,04% 2,5 g
ßphenylethylalcool 0,4 g
Citrate buffer pH 6.05 - 586 mOsmol/L 47,70 g g
4°C Protect from light
21 Day
3182


  Mentions Légales